Novavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 Transcript

Core Insights - Novavax is an innovative biotech company focused on vaccine development, having undergone significant transformation post-pandemic to enhance its technology and create value [2][3] - The company has shifted from a single product focus during the pandemic to a more diversified approach, aiming to strengthen its financial position while exploring multiple value creation opportunities [3] Company Overview - Novavax has developed a vertically integrated structure that initially incurred high expenses but also presented substantial opportunities [3] - The leadership team has worked on reducing the expense base, improving the balance sheet, and extending the cash runway while maintaining operational capabilities [3]